Stocks
NeoGenomics, Inc.NEO
NASDAQHealthcareDiagnostics & Research$7.88-1.25%
Provides cancer-focused genetic and molecular testing services used by oncologists, hospitals, and pharmaceutical companies to guide diagnosis, treatment selection, and clinical research. The company operates clinical laboratories that analyze tumor samples and also offers biomarker testing and data...
Market Cap: $204.6M52W Range: $4.72 – $13.74
Congressional Interest in NeoGenomics, Inc. (NEO)
5 members of Congress have disclosed 7 trades in NeoGenomics, Inc. (NEO), a Healthcare company. The buy/sell breakdown shows 5 purchases versus 2 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
7
Unique Politicians
5
Buys
5
Sells
2
Who in Congress Is Trading NEO?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2025-05-07 | Gilbert Cisneros | buy | $1K – $15K |
| 2022-03-30 | Dwight Evans | sell | $1K – $15K |